Spectral AI, Inc.
MDAIHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeSpectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company carries a $50.5M market cap, placing it firmly in the micro-cap category. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds.
Market Cap
$50.5M
Beta
1.18
P/E (TTM)
—
P/E (Fwd)
-1.67
EPS (TTM)
$-0.32
EPS (Fwd)
$-0.94
ROE
—
ROA
-41.9%
Cash
$14.0M
Total Debt
$16.3M
Free CF
-$6.6M
52W Change
-16.6%
Annual Financials
Cash vs Debt
Where MDAI stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, MDAI finished 10.34% below its 150-day moving average ($1.74) and 7.69% below its 200-day moving average ($1.69). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is MDAI overbought or oversold?
At the September 3, 2026 close, MDAI's RSI(14) was 28.0, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $14.0M in cash, though total debt stands at $16.3M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company is burning cash, with free cash flow at -$6.6M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Revenue has pulled back from $25.4M (2022) to $19.6M (2025), a 23% decline worth watching.
The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing MDAI.